
Alignment of PIM-1 Inhibitors with PharmScreen
Pim-1 is an oncogene-encoded serine/threonine kinase. Originally identified in Maloney murine leukaemia, it is involved in several cellular functions associated with survival an proliferation which
Pim-1 is an oncogene-encoded serine/threonine kinase. Originally identified in Maloney murine leukaemia, it is involved in several cellular functions associated with survival an proliferation which
Computational chemistry has been embraced by drug discovery as a key complementary technology to medicinal and organic chemistry [1]. For instance, several big pharmaceutical companies
Virtual screening is a well-known approach in drug discovery projects to find new leads in virtual libraries of small molecules, but it is not clear
By Alessandro Deplano – Sep. 20, 2017 NOTE: THERE IS A NEW VERSION OF THIS SCRIPT. VISIT THIS PAGE TO DOWNLOAD IT. Conformer generation is
Enric Herrero, Pharmacelera’s CTO, is giving a talk about conformation generation at the RDKit User Group Meeting, held in Berlin from Sept 20th to Sept
Check out our new user interface for PharmScreen! Perform virtual screening campaigns with just a few clicks and take advantage of Pharmacelera’s unique 3D hydrophobic
PharmScreen field-based alignment outperforms traditional solutions by taking into account relevant ligand characteristics related with ligand-receptor interaction.PharmScreen superior alignment allows finding better leads in a
Using scientific software can be frustrating and time-consuming if user experience has not been taken into account, resulting in less productive research. In order to
Does the accuracy of quantum-mechanical (QM) descriptors at density functional theory (DFT) level justify its computational requirements for molecular superposition? In this graph, we compare
Pharmacelera is going to attend BIO International Convention this June in San Diego. Don’t miss the opportunity to meet us and know more about PharmScreen,
The Center for the Development of Industrial Technology ranks Pharmacelera in the top 5% most innovative companies of 2016 and, as such, it awards the
This image shows a successful small-molecule alignment using a multi-reference strategy on a set of D2/D4 inhibitors. As it can be observed, using two references
Pharmacelera has recently moved its offices to the Barcelona Tech City space (Pier 01) in the Barceloneta neighbourhood. Barcelona Tech City was inaugurated in July
Pharmacelera has been selected as one of the finalists of the Startup Challenge 2016 program organized by the Pistoia Alliance! This is an alliance from
Pharmacelera has attended BIOSPAIN 2016 in Bilbao. BIOSPAIN is the largest biotech event organized by a national bioindustry association in Europe and one of the
After receiving the Seal-Of-Excellence from the European Union SME Instrument program under the umbrella of the H2020 framework, Pharmacelera has been awarded an Horizonte Pyme
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Privacy & Cookies policy